Magnetic resonance imaging with side effects

Great care should be taken when performing magnetic resonance imaging (MRI) in patients with a cardiac pacemaker. Henning Bovenschulte and his co-authors review recent findings in the latest issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2012; 109[15]: 270-5).

MRI is generally contraindicated in patients with a pacemaker (PM) or an implantable cardiac defibrillator (ICD), because of the risk of life-threatening events. The devices and their sensors may interact with the magnetic fields, disrupting the cardiac rhythm. Energy builds up in the electrode leads, which act as an antenna, and is discharged into the tissues around the tip of the electrode.

The principal published studies, complemented by the authors' own data, yielded a total of 1043 patients with a PM or ICD who had undergone MRI. No life-threatening complications were observed. In 11 cases electrical resetting of the device was necessary, and a significant increase in pacing threshold was seen in 16 cases.

Despite the potential hazards, MRI is occasionally indicated in a seriously ill patient. Provided appropriate steps are taken to optimize the procedure, the benefits of MRI will clearly outweigh the risks.

More information: www.aerzteblatt.de

Provided by Deutsches Aerzteblatt International

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA approves first MRI-safe pacemaker

Feb 08, 2011

The US Food and Drug Administration on Monday approved the first pacemaker system -- produced by medical device giant Medtronic Inc. -- that can be used safely with MRI scanners.

Recommended for you

Hormonal therapy for transsexualism safe and effective

Jun 18, 2013

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

User comments

More news stories

One in four stroke patients suffer PTSD

One in four people who survive a stroke or transient ischemic attack (TIA) suffer from symptoms of post-traumatic stress disorder (PTSD) within the first year post-event, and one in nine experience chronic PTSD more than ...